Ensuring continuity of patient care across the healthcare interface Telephone follow-up post-hospitalization

Mohanad Odeh, Claire Scullin, Glenda Fleming, Michael G Scott, Robert Horne, James C McElnay

Research output: Contribution to journalArticle

2 Citations (Scopus)
9 Downloads (Pure)

Abstract

AIMS: To implement pharmacist-led, postdischarge telephone follow-up (TFU) intervention and to evaluate its impact on rehospitalization parameters in polypharmacy patients, via comparison with a well-matched control group.

METHOD: Pragmatic, prospective, quasi-experimental study. Intervention patients were matched by propensity score techniques with a control group. Guided by results from a pilot study, clinical pharmacists implemented TFU intervention, added to routine integrated medicines management service.

RESULTS: Using an intention to treat approach, reductions in 30- and 90-day readmission rates for intervention patients compared with controls were 9.9% [odds ratio = 0.57; 95% confidence interval (CI): 0.36-0.90; P < 0.001] and 15.2% (odds ratio = 0.53; 95% CI: 0.36-0.79; P = 0.021) respectively. Marginal mean time to readmission was 70.9 days (95% CI: 66.9-74.9) for intervention group compared with 60.1 days (95% CI: 55.4-64.7) for controls. Mean length of hospital stay compared with control was (8.3 days vs. 6.7 days; P < 0.001). Benefit: cost ratio for 30-day readmissions was 29.62, and 23.58 for 90-day interval. Per protocol analyses gave more marked improvements. In intervention patients, mean concern scale score, using Beliefs about Medicine Questionnaire, was reduced 3.2 (95% CI: -4.22 to -2.27; P < 0.001). Mean difference in Medication Adherence Report Scale was 1.4 (22.7 vs. 24.1; P < 0.001). Most patients (83.8%) reported having better control of their medicines after the intervention.

CONCLUSIONS: Pharmacist-led postdischarge structured TFU intervention can reduce 30- and 90-day readmission rates. Positive impacts were noted on time to readmission, length of hospital stay upon readmission, healthcare costs, patient beliefs about medicines, patient self-reported adherence and satisfaction.

Original languageEnglish
Pages (from-to)616-625
JournalBritish Journal of Clinical Pharmacology
Volume85
Issue number3
Early online date24 Jan 2019
DOIs
Publication statusPublished - 18 Feb 2019

Fingerprint

Continuity of Patient Care
Telephone
Hospitalization
Delivery of Health Care
Confidence Intervals
Length of Stay
Pharmacists
Odds Ratio
Polypharmacy
Propensity Score
Control Groups
Medication Adherence
Health Care Costs
Cost-Benefit Analysis
Research Design
Medicine

Bibliographical note

© 2019 The British Pharmacological Society.

Cite this

Odeh, Mohanad ; Scullin, Claire ; Fleming, Glenda ; Scott, Michael G ; Horne, Robert ; McElnay, James C. / Ensuring continuity of patient care across the healthcare interface Telephone follow-up post-hospitalization. In: British Journal of Clinical Pharmacology. 2019 ; Vol. 85, No. 3. pp. 616-625.
@article{706f26d5bcbf4ce38b773adeaa07ed25,
title = "Ensuring continuity of patient care across the healthcare interface Telephone follow-up post-hospitalization",
abstract = "AIMS: To implement pharmacist-led, postdischarge telephone follow-up (TFU) intervention and to evaluate its impact on rehospitalization parameters in polypharmacy patients, via comparison with a well-matched control group.METHOD: Pragmatic, prospective, quasi-experimental study. Intervention patients were matched by propensity score techniques with a control group. Guided by results from a pilot study, clinical pharmacists implemented TFU intervention, added to routine integrated medicines management service.RESULTS: Using an intention to treat approach, reductions in 30- and 90-day readmission rates for intervention patients compared with controls were 9.9{\%} [odds ratio = 0.57; 95{\%} confidence interval (CI): 0.36-0.90; P < 0.001] and 15.2{\%} (odds ratio = 0.53; 95{\%} CI: 0.36-0.79; P = 0.021) respectively. Marginal mean time to readmission was 70.9 days (95{\%} CI: 66.9-74.9) for intervention group compared with 60.1 days (95{\%} CI: 55.4-64.7) for controls. Mean length of hospital stay compared with control was (8.3 days vs. 6.7 days; P < 0.001). Benefit: cost ratio for 30-day readmissions was 29.62, and 23.58 for 90-day interval. Per protocol analyses gave more marked improvements. In intervention patients, mean concern scale score, using Beliefs about Medicine Questionnaire, was reduced 3.2 (95{\%} CI: -4.22 to -2.27; P < 0.001). Mean difference in Medication Adherence Report Scale was 1.4 (22.7 vs. 24.1; P < 0.001). Most patients (83.8{\%}) reported having better control of their medicines after the intervention.CONCLUSIONS: Pharmacist-led postdischarge structured TFU intervention can reduce 30- and 90-day readmission rates. Positive impacts were noted on time to readmission, length of hospital stay upon readmission, healthcare costs, patient beliefs about medicines, patient self-reported adherence and satisfaction.",
author = "Mohanad Odeh and Claire Scullin and Glenda Fleming and Scott, {Michael G} and Robert Horne and McElnay, {James C}",
note = "{\circledC} 2019 The British Pharmacological Society.",
year = "2019",
month = "2",
day = "18",
doi = "10.1111/bcp.13839",
language = "English",
volume = "85",
pages = "616--625",
journal = "British Journal of Clinical Pharmacology",
issn = "0306-5251",
publisher = "Wiley-Blackwell",
number = "3",

}

Ensuring continuity of patient care across the healthcare interface Telephone follow-up post-hospitalization. / Odeh, Mohanad; Scullin, Claire; Fleming, Glenda; Scott, Michael G; Horne, Robert; McElnay, James C.

In: British Journal of Clinical Pharmacology, Vol. 85, No. 3, 18.02.2019, p. 616-625.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Ensuring continuity of patient care across the healthcare interface Telephone follow-up post-hospitalization

AU - Odeh, Mohanad

AU - Scullin, Claire

AU - Fleming, Glenda

AU - Scott, Michael G

AU - Horne, Robert

AU - McElnay, James C

N1 - © 2019 The British Pharmacological Society.

PY - 2019/2/18

Y1 - 2019/2/18

N2 - AIMS: To implement pharmacist-led, postdischarge telephone follow-up (TFU) intervention and to evaluate its impact on rehospitalization parameters in polypharmacy patients, via comparison with a well-matched control group.METHOD: Pragmatic, prospective, quasi-experimental study. Intervention patients were matched by propensity score techniques with a control group. Guided by results from a pilot study, clinical pharmacists implemented TFU intervention, added to routine integrated medicines management service.RESULTS: Using an intention to treat approach, reductions in 30- and 90-day readmission rates for intervention patients compared with controls were 9.9% [odds ratio = 0.57; 95% confidence interval (CI): 0.36-0.90; P < 0.001] and 15.2% (odds ratio = 0.53; 95% CI: 0.36-0.79; P = 0.021) respectively. Marginal mean time to readmission was 70.9 days (95% CI: 66.9-74.9) for intervention group compared with 60.1 days (95% CI: 55.4-64.7) for controls. Mean length of hospital stay compared with control was (8.3 days vs. 6.7 days; P < 0.001). Benefit: cost ratio for 30-day readmissions was 29.62, and 23.58 for 90-day interval. Per protocol analyses gave more marked improvements. In intervention patients, mean concern scale score, using Beliefs about Medicine Questionnaire, was reduced 3.2 (95% CI: -4.22 to -2.27; P < 0.001). Mean difference in Medication Adherence Report Scale was 1.4 (22.7 vs. 24.1; P < 0.001). Most patients (83.8%) reported having better control of their medicines after the intervention.CONCLUSIONS: Pharmacist-led postdischarge structured TFU intervention can reduce 30- and 90-day readmission rates. Positive impacts were noted on time to readmission, length of hospital stay upon readmission, healthcare costs, patient beliefs about medicines, patient self-reported adherence and satisfaction.

AB - AIMS: To implement pharmacist-led, postdischarge telephone follow-up (TFU) intervention and to evaluate its impact on rehospitalization parameters in polypharmacy patients, via comparison with a well-matched control group.METHOD: Pragmatic, prospective, quasi-experimental study. Intervention patients were matched by propensity score techniques with a control group. Guided by results from a pilot study, clinical pharmacists implemented TFU intervention, added to routine integrated medicines management service.RESULTS: Using an intention to treat approach, reductions in 30- and 90-day readmission rates for intervention patients compared with controls were 9.9% [odds ratio = 0.57; 95% confidence interval (CI): 0.36-0.90; P < 0.001] and 15.2% (odds ratio = 0.53; 95% CI: 0.36-0.79; P = 0.021) respectively. Marginal mean time to readmission was 70.9 days (95% CI: 66.9-74.9) for intervention group compared with 60.1 days (95% CI: 55.4-64.7) for controls. Mean length of hospital stay compared with control was (8.3 days vs. 6.7 days; P < 0.001). Benefit: cost ratio for 30-day readmissions was 29.62, and 23.58 for 90-day interval. Per protocol analyses gave more marked improvements. In intervention patients, mean concern scale score, using Beliefs about Medicine Questionnaire, was reduced 3.2 (95% CI: -4.22 to -2.27; P < 0.001). Mean difference in Medication Adherence Report Scale was 1.4 (22.7 vs. 24.1; P < 0.001). Most patients (83.8%) reported having better control of their medicines after the intervention.CONCLUSIONS: Pharmacist-led postdischarge structured TFU intervention can reduce 30- and 90-day readmission rates. Positive impacts were noted on time to readmission, length of hospital stay upon readmission, healthcare costs, patient beliefs about medicines, patient self-reported adherence and satisfaction.

U2 - 10.1111/bcp.13839

DO - 10.1111/bcp.13839

M3 - Article

C2 - 30675742

VL - 85

SP - 616

EP - 625

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

SN - 0306-5251

IS - 3

ER -